130 related articles for article (PubMed ID: 6134293)
1. Unsaturated fatty acids and platelet aggregation: in vitro study.
Srivastava KC; Awasthi KK
Prostaglandins Leukot Med; 1983 Apr; 10(4):465-72. PubMed ID: 6134293
[TBL] [Abstract][Full Text] [Related]
2. Unsaturated fatty acids inhibit ADP- arachidonate-induced platelet aggregation without affecting thromboxane synthesis.
Dratewka-Kos E; Tinker DO; Kindl B
Biochem Cell Biol; 1986 Sep; 64(9):906-13. PubMed ID: 3778664
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process.
Sato T; Nakao K; Hashizume T; Fujii T
Biochim Biophys Acta; 1987 Nov; 931(2):157-64. PubMed ID: 3663714
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet function by cis-unsaturated fatty acids.
MacIntyre DE; Hoover RL; Smith M; Steer M; Lynch C; Karnovsky MJ; Salzman EW
Blood; 1984 Apr; 63(4):848-57. PubMed ID: 6322886
[TBL] [Abstract][Full Text] [Related]
5. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.
Willis AL; Comai K; Kuhn DC; Paulsrud J
Prostaglandins; 1974 Dec; 8(6):509-19. PubMed ID: 4462154
[No Abstract] [Full Text] [Related]
6. Acetylenic analog of arachidonate that acts like aspirin on platelets.
Willis AL; Kuhn DC; Weiss HJ
Science; 1974 Jan; 183(4122):327-30. PubMed ID: 4809077
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on the effect of cis (oleic, linoleic) and trans (elaidic, linoelaidic) fatty acids on the in vitro prostaglandin biosynthesis in human blood platelets from (1-14C) arachidonic acid.
Srivastava KC; Awasthi KK
Prostaglandins Leukot Med; 1982 Dec; 9(6):669-84. PubMed ID: 6818563
[TBL] [Abstract][Full Text] [Related]
8. Effects of supplementation with unsaturated fatty acids on plasma and membrane lipid composition and platelet function in patients with cirrhosis and defective aggregation.
Marra F; Riccardi D; Melani L; Spadoni S; Galli C; Fabrizio P; Tosti-Guerra C; Carloni V; Gentilini P; Laffi G
J Hepatol; 1998 Apr; 28(4):654-61. PubMed ID: 9566835
[TBL] [Abstract][Full Text] [Related]
9. 9 alpha-homo-9,11-epoxy-5,13-prostadienoic acid analogues: specific stable agonist (SQ 26, 538) and antagonist (SQ 26, 536) of the human platelet thromboxane receptor.
Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Heikes JE; Sprague PW; Antonaccio MJ
Prostaglandins; 1981 Aug; 22(2):295-307. PubMed ID: 6270744
[TBL] [Abstract][Full Text] [Related]
10. Effect of ketotifen and disodium cromoglycate on human platelet aggregation.
García Mesa M; Arruzazabala Valmaña ML
Allergol Immunopathol (Madr); 1989; 17(1):33-4. PubMed ID: 2502003
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of blood platelet aggregation by dioxo-ene compounds.
Graff G; Gellerman JL; Sand DM; Schlenk H
Biochim Biophys Acta; 1984 Jun; 799(2):143-50. PubMed ID: 6428462
[TBL] [Abstract][Full Text] [Related]
12. Effects of all cis-5,8,11,14,17 eicosapentaenoic acid and PGH3 on platelet aggregation.
Gryglewski RJ; Salmon JA; Ubatuba FB; Weatherly BC; Moncada S; Vane JR
Prostaglandins; 1979 Sep; 18(3):453-78. PubMed ID: 531220
[No Abstract] [Full Text] [Related]
13. [Effect of a new thromboxane A2 antagonist, S-145, on platelet aggregation].
Kakushi H; Shike T; Uchida K
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):171-8. PubMed ID: 2731807
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
Fenn CG; Littleton JM
Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
[TBL] [Abstract][Full Text] [Related]
15. Labile aggregation stimulating substance, free fatty acids, and platelet aggregation.
Gerrard JM; White JG; Krivit W
J Lab Clin Med; 1976 Jan; 87(1):73-82. PubMed ID: 1245785
[TBL] [Abstract][Full Text] [Related]
16. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
17. Eskimo plasma constituents, dihomo-gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid inhibit the release of atherogenic mitogens.
Smith DL; Willis AL; Nguyen N; Conner D; Zahedi S; Fulks J
Lipids; 1989 Jan; 24(1):70-5. PubMed ID: 2545997
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-chain cis-unsaturated fatty acids and their alcohol analogs on aggregation of bovine platelets and their relation with membrane fluidity change.
Kitagawa S; Endo J; Kametani F
Biochim Biophys Acta; 1985 Sep; 818(3):391-7. PubMed ID: 4041445
[TBL] [Abstract][Full Text] [Related]
19. Effect of some saturated and unsaturated fatty acids on prostaglandin biosynthesis in washed human blood platelets from (1-14 C)arachidonic acid.
Srivastava KC; Awasthi KK; Lindegård P; Tiwari KP
Prostaglandins Leukot Med; 1982 Mar; 8(3):219-37. PubMed ID: 6952288
[TBL] [Abstract][Full Text] [Related]
20. High concentrations of arachidonic acid induce platelet aggregation and serotonin release independent of prostaglandin endoperoxides and thromboxane A2.
Hashimoto Y; Naito C; Kume S; Kato H; Watanabe T; Kawamura M; Teramoto T; Oka H
Biochim Biophys Acta; 1985 Sep; 841(3):283-91. PubMed ID: 2992603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
